Few novel antibiotics in the pipeline, WHO warnsBMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4339 (Published 19 September 2017) Cite this as: BMJ 2017;358:j4339
- Zosia Kmietowicz
- The BMJ
The World Health Organization has reiterated its warning that there is a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.
Only eight of the 51 new antibiotics and biologicals in clinical development to treat antibiotic resistant pathogens are innovative treatments that could add value to the current drugs on offer, a new report from the agency has found.1
Most of the drugs in the clinical pipeline are modifications of existing classes of antibiotics and are only short term solutions, …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.